Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
3 studies found for:    fkd
Show Display Options
Rank Status Study
1 Recruiting Geko Neuromuscular Stimulator vs Thromboembolism Deterrent Stockings (TEDS): DVT Prevention Study
Condition: Deep Vein Thrombosis
Interventions: Device: geko™ post-surgery for 48hrs then 4hrs/day until discharge.;   Device: TEDS post-surgery for 48hrs then 4hrs/day until discharge.
2 Active, not recruiting Intravesical Administration of INSTILADRIN (rAd-IFN With Syn3) in Patients With Bladder Cancer
Condition: Superficial Bladder Cancer
Intervention: Drug: INSTILADRIN
3 Active, not recruiting Phase IB Intravesical Administration of SCH 721015
Condition: Bladder Cancer
Intervention: Drug: SCH 721015

Indicates status has not been verified in more than two years